Effectiveness of vedolizumab for Crohn's disease with spondyloarthritis in fail with two TNF blocking agents

Saved in:
Bibliographic Details
Published inJoint, bone, spine : revue du rhumatisme Vol. 85; no. 4; pp. 495 - 496
Main Authors Banse, Christopher, Armengol-Debeir, Laura, Vittecoq, Olivier
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 01.07.2018
Elsevier Masson
Subjects
Adrenal Cortex Hormones - therapeutic use
Adult
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized - therapeutic use
Crohn Disease - complications
Crohn Disease - diagnosis
Crohn Disease - drug therapy
Crohn's disease
Drug Therapy, Combination
Female
Follow-Up Studies
Human health and pathology
Humans
Infliximab - therapeutic use
Life Sciences
Nephrotic syndrom
Spondylarthritis - complications
Spondylarthritis - diagnosis
Spondylarthritis - drug therapy
Spondyloarthritis
Sulfasalazine - therapeutic use
Treatment Outcome
Vedolizumab
Nephrotic syndrom
Crohn's disease
Vedolizumab
Spondyloarthritis
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 23
ObjectType-Report-3
ObjectType-Review-2
ObjectType-Case Study-4
ISSN:1297-319X
1778-7254
DOI:10.1016/j.jbspin.2017.06.006